Dr Felocelia Deladisma Alcid, MD | |
W.38 Glen Avenue, Paramus, NJ 07652-2324 | |
(201) 447-0785 | |
(973) 890-4574 |
Full Name | Dr Felocelia Deladisma Alcid |
---|---|
Gender | Female |
Speciality | General Practice |
Location | W.38 Glen Avenue, Paramus, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124062344 | NPI | - | NPPES |
001638B1J | Other | MEDICAL BILLING NUMBER | |
2840502 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 25MA02464300 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Felocelia Deladisma Alcid, MD 38 Glen Ave, Paramus, NJ 07652-2326 Ph: (201) 447-0785 | Dr Felocelia Deladisma Alcid, MD W.38 Glen Avenue, Paramus, NJ 07652-2324 Ph: (201) 447-0785 |
News Archive
Researchers at Tokyo Institute of Technology, Imperial College London and the University of Tokyo have demonstrated that physical coordination is more beneficial in larger groups.
Researchers comparing leading treatment approaches for patients with severe uveitis have discovered that systemic therapy with oral corticosteroids and immunosuppression can preserve or improve vision in the long term better than regional implant therapy can.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent Systemâ„¢ for the treatment of coronary artery disease.
Parkinson's experts across the world have been reporting a remarkable phenomenon - many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.
The Food and Drug Administration (FDA) today formally notified manufacturers of pancreatic insufficiency products that these drugs must get approval by FDA within the next four years in order to remain on the market.
› Verified 7 days ago
Shiva Kumar Kotturi, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 37 W Century Rd Ste 111, Paramus, NJ 07652 Phone: 201-262-2244 Fax: 201-262-2246 |